What is the clinical effectiveness and cost-effectiveness of cytisine compared with varenicline for smoking cessation? A systematic review and economic evaluation.
about
Nicotine receptor partial agonists for smoking cessationOrthosteric and Allosteric Ligands of Nicotinic Acetylcholine Receptors for Smoking CessationA Systematic Review of Smoking Cessation Interventions for Adults in Substance Abuse Treatment or RecoveryHealth-care interventions to promote and assist tobacco cessation: a review of efficacy, effectiveness and affordability for use in national guideline developmentNew Pharmacological Agents to Aid Smoking Cessation and Tobacco Harm Reduction: What Has Been Investigated, and What Is in the Pipeline?Estimating the Expected Value of Sample Information Using the Probabilistic Sensitivity Analysis Sample: A Fast, Nonparametric Regression-Based Method.Development and Application of an Economic Model (EQUIPTMOD) to assess the Impact of Smoking Cessation.How do smoking cessation medicines compare with respect to their neuropsychiatric safety? A protocol for a systematic review, network meta-analysis and cost-effectiveness analysis.The COPD Pipeline, XXVI.Sophora alopecuroides L. var. alopecuroides alleviates morphine withdrawal syndrome in mice: involvement of alkaloid fraction and matrineWhat phytotherapy needs: Evidence-based guidelines for better clinical practice.Getting cytisine licensed for use world-wide: a call to action.Cost-equivalence and Pluralism in Publicly-funded Health-care Systems.Assessment of cost-effective changes to the current and potential provision of smoking cessation services: an analysis based on the EQUIPTMOD.Estimates of costs for modelling return on investment from smoking cessation interventions.An examination of user costs in relation to smokers using a cessation service based in the UK.
P2860
Q24185773-DC90F25F-1B83-4DC4-9D3E-038AC5C33874Q26774830-B3FD69C6-441F-4137-9928-309140A9A6CFQ27322109-A5F07DC1-1521-4A85-A782-841E3CB2BBD1Q28086911-06D8A390-DC9B-4133-9F55-20993A024A02Q28277165-198006A0-88AB-4320-BF40-7BB85626D7F3Q35752778-8D9731EB-EC19-4B4B-AF9E-CD69ACDE9F5DQ38611963-6D58973E-1CA4-4778-A7BA-0322741D7DB5Q38720906-3045AB3C-7B0E-4B3E-9661-8D07BDE9405AQ41398563-1ABEE93F-AD41-49D4-9621-52FFD90B3095Q42368290-4831FA5B-7C86-454D-9651-505679FFE8EBQ47386651-685143F7-F8EC-4F00-A560-C54851ADD810Q48156268-42CB1716-6C3F-46E3-9901-026540D802DDQ48375575-BC4CDEAD-88B3-4892-A472-05071AC5BF1AQ50048057-745C71BF-DBAB-48F6-AEC0-3B167495D45CQ50532013-7598735D-9C44-484B-BEF5-9B6133F36FD0Q55003151-EA40D2D5-C171-4DAE-A342-EA808659765A
P2860
What is the clinical effectiveness and cost-effectiveness of cytisine compared with varenicline for smoking cessation? A systematic review and economic evaluation.
description
2014 nî lūn-bûn
@nan
2014 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
What is the clinical effective ...... eview and economic evaluation.
@ast
What is the clinical effective ...... eview and economic evaluation.
@en
type
label
What is the clinical effective ...... eview and economic evaluation.
@ast
What is the clinical effective ...... eview and economic evaluation.
@en
prefLabel
What is the clinical effective ...... eview and economic evaluation.
@ast
What is the clinical effective ...... eview and economic evaluation.
@en
P2093
P50
P356
P1476
What is the clinical effective ...... eview and economic evaluation.
@en
P2093
Joanna Leaviss
Matt Stevenson
William Sullivan
P356
10.3310/HTA18330
P577
2014-05-01T00:00:00Z